Form 4: Alpha Tau Medical Officer Trades Shares

Alpha Tau Medical Ltd. reports a transaction by its Chief Financial Officer, Raphi Levy, involving the purchase of 20,000 ordinary shares.

Summary

• Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., reported a transaction on June 30, 2026.
• The transaction involved the acquisition of 20,000 ordinary shares at a price of $12.0022 per share.
• Following this transaction, Mr. Levy beneficially owns 90,180 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider transaction without providing new financial or strategic information.

Positives

• The Chief Financial Officer's direct purchase of company shares can be interpreted as a positive signal of confidence in the company's future prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider share purchases, as reported in Form 4 filings, are closely watched by investors as they can indicate management's belief in the company's valuation and future performance within the medical technology sector.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive indicator of confidence in the company's stock.

Key Dates

Keywords

Alpha Tau Medical, Form 4, Insider Trading, Share Purchase, Raphi Levy, Chief Financial Officer, Beneficial Ownership